Serum Institute of India buys 50% of Schott Kaisha pharma packaging

Germany’s specialty glass company Schott has a new partner. Serum Institute of India, the world‘s largest vaccine producer and manufacturer of highly-effective biologics, has bought 50% stake in the Indian joint venture Schott Kaisha from former co-owners Kairus Dadachanji and Shapoor Mistry. The joint venture is the leading Indian manufacturer of pharma packaging products such as vials, syringes, ampoules and cartridges used to package life-saving medications. With this acquisition, Serum is securing its supply of high-quality pharma packaging amid rising global demand. Adar Poonawalla, chief executive officer Serum Institute of India Adar Poonawalla, CEO of Serum Institute of India says, “Even the best medication can’t reach the patient without the right packaging. Securing this supply chain is of strategic importance. Schott is the perfect partner for us to do this because of their expertise and global network. As a longtime customer, we use their vials, ampoules and syringes to store our vaccines including Covishield. Working even closer together is in the best interest of global health.” SCHOTT CEO Dr Frank Heinricht Dr Frank Heinricht, CEO Schott,…

Choose your subscription to read more